NCT00190710View on ClinicalTrials.gov

A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients With Non-Small-Cell Lung Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

242

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

August 31, 2007

Conditions
Non-Small Cell Lung Cancer
Interventions
DRUG

Gemcitabine

DRUG

Carboplatin

Trial Locations (1)

75204

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Dallas

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT00190710 - A Trial of Carboplatin and Gemcitabine Versus Gemcitabine Alone in Patients With Non-Small-Cell Lung Cancer | Biotech Hunter | Biotech Hunter